Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015, Article ID 234878, 3 pages
http://dx.doi.org/10.1155/2015/234878
Case Report

Antiphospholipid Syndrome in a Pregnant Female Presenting with Severe Thrombocytopenia and Bleeding

1Department of Medicine, PGIMS Rohtak, Haryana 124001, India
2Department of Medicine, KGMC, Lucknow 226008, India

Received 7 December 2014; Accepted 9 January 2015

Academic Editor: Masahiro Kohzuki

Copyright © 2015 Kunal Mahajan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Galli, G. Finazzi, and T. Barbui, “Thrombocytopenia in the antiphospholipid syndrome,” British Journal of Haematology, vol. 93, no. 1, pp. 1–5, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Cuadrado, F. Mujic, E. Muñoz, M. A. Khamashta, and G. R. V. Hughes, “Thrombocytopenia in the antiphospholipid syndrome,” Annals of the Rheumatic Diseases, vol. 56, no. 3, pp. 194–196, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Finazzi, “The Italian registry of antiphospholipid antibodies,” Haematologica, vol. 82, no. 1, pp. 101–105, 1997. View at Google Scholar · View at Scopus
  5. I. Uthman, B. Godeau, A. Taher, and M. Khamashta, “The hematologic manifestations of the antiphospholipid syndrome,” Blood Reviews, vol. 22, no. 4, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Galli, M. Daldossi, and T. Barbui, “Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies,” Thrombosis and Haemostasis, vol. 71, no. 5, pp. 571–575, 1994. View at Google Scholar · View at Scopus
  7. L. Macchi, P. Rispal, G. Clofent-Sanchez et al., “Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia,” British Journal of Haematology, vol. 98, no. 2, pp. 336–341, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Campbell, S. S. Pierangeli, S. Wellhausen, and E. N. Harris, “Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation,” Thrombosis and Haemostasis, vol. 73, no. 3, pp. 529–534, 1995. View at Google Scholar · View at Scopus
  9. S. S. Pierangeli, P. P. Chen, E. Raschi et al., “Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms,” Seminars in Thrombosis and Hemostasis, vol. 34, no. 3, pp. 236–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Erkan, H. Bateman, and M. D. Lockshin, “Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature,” Lupus, vol. 8, no. 7, pp. 560–564, 1999. View at Publisher · View at Google Scholar · View at Scopus